Uncategorized

Entries open for Katherine Schneider Journalism Award and Gary Corcoran Student Prize for Excellence in Disability Reporting

PHOENIX – The National Center on Disability and Journalism (NCDJ) is now accepting entries for the 2024 Katherine Schneider Journalism Award and the Gary Corcoran Student Prize for Excellence in Reporting on Disability.

The Schneider prize is the only professional journalism contest devoted exclusively to disability coverage. It is supported by a gift from Katherine Schneider, a retired clinical psychologist who has been blind since birth. Schneider wants to encourage journalists to improve their coverage of disability issues, moving beyond “inspirational” stories that don’t accurately represent the lives of people with disabilities.

“There are so many worthy stories that need to be told, and with the NCDJ contest, we’re able to showcase many from around the world and recognize those properly conveying the needs, the struggles and the successes alike,” Schneider said.

In the professional contest, winners will receive a total of $8,000 in cash awards in large and small media categories. First-place winners in each category receive $2,500 and an invitation to speak about their work at an awards ceremony at ASU’s Walter Cronkite School of Journalism and Mass Communication. Second-place winners receive $1,000, and third-place winners get $500.

For the third year, the Gary Corcoran Student Prize for Excellence in Reporting on Disability, which recognizes the best work by college journalists on topics related to disabilities, also will be awarded.

The Corcoran student award honors the life and advocacy of the late Gary Corcoran, a wheelchair user from the age of 19 who worked to improve accessibility of housing, public transit, air travel and public venues across Phoenix. Prize amounts are $2,500 for first place, $1,500 for second place and $1,000 for third place. Entrants must have been enrolled as a student at the time of publication or broadcast, and the work must have appeared in a university-affiliated publication or program.

The award is funded by a gift from Gary’s sister, journalist Katherine Corcoran, who said her brother “was a tireless advocate for accessibility in the Phoenix metro area.”

“He knew firsthand the challenges that people with disabilities face, and good journalism – good storytelling – helps us understand as a society the importance of access and inclusion,” she said. “That’s why it’s so important to recognize students, the future of journalism, who are doing this work.”

Journalists working in digital, print, audio and broadcast media are eligible to enter both contests. Entries are accepted from outside the U.S., although the work submitted must be in English.

Entries for both contests must have been published or aired between July 1, 2023, and Dec. 31, 2024. The deadline to enter is Jan. 10, 2025. There is no entry fee, and reporters may self-nominate.

The entry form for the Schneider professional prize can be found at Schneider Prize Entry 2024 and for the Corcoran student prize at Corcoran Prize Entry 2024.

“These awards spotlight the ever-improving coverage across the globe of issues related to disability. We continue to see hard-hitting and innovative work that serves to educate the public and bring needed changes,” said Pauline Arrillaga, executive director of the NCDJ.

Entries are judged by professional journalists and experts on disability issues. Past judges have included PBS NewsHour anchor Judy Woodruff; Tony Coelho, former six-term U.S. congressman from California and the primary sponsor of the Americans with Disabilities Act; and Daniel Burke, former religion editor at CNN.

In 2023, first place in the Schneider Award Large Media category went to Beth Hundsdorfer of Capitol News Illinois and Molly Parker of Lee Enterprises Midwest for “Culture of Cruelty,” an investigative series produced as part of ProPublica’s Local Reporting Network. The second-place winner was former New York Times reporter Amanda Morris for her innovative look at how American Sign Language has been transformed by video technology and social media. Third place went to Christine Herman for her Side Effects Public Media story examining the barriers families face in finding appropriate mental health care for children and teens.

In the Schneider Award Small Media category, first place honors last year went to Caroline Ghisolfi, Tony Plohetski and Nicole Foy of the Austin American-Statesman for “Disabled & Abandoned,” which found that Texas’ system of care for people with disabilities is beset by crisis and violence. Illustrator John Greiner placed second for his comic series “Tales to Demystify: Not Welcome Here.” Placing third was Jennifer Dixon of the Detroit Free Press for “Rights & Wrongs.”

In the Corcoran contest, last year’s first-place winner was Meagan Gillmore, a graduate student at Carleton University in Ottawa whose winning entry looked at criticism among people with disabilities over assisted dying laws in Canada. Second place went to Julia Métraux for a piece that stemmed from a climate change course she took at the Graduate School of Journalism at the University of California, Berkeley. Placing third were Erin Gretzinger, Christy Klein and Erin McGroarty of the University of Wisconsin-Madison for a story that explored past, present and future efforts, as well as challenges, to serve people with disabilities in Wisconsin.

The 2023 NCDJ contests garnered almost 200 entries from around the globe, including from journalists in Brazil, Uganda and Pakistan.

About The National Center on Disability and Journalism (NCDJ)The Schneider and Corcoran awards are both administered by the NCDJ, which is part of the Walter Cronkite School of Journalism and Mass Communication at Arizona State University. The NCDJ offers resources and materials for journalists covering disability issues and topics, including a widely used disability language stylebook. To learn more visit our website here.

Contact:

NCDJ Executive Director Pauline Arrillaga

(602)717-7979

pauline.arrillaga@asu.edu

Rybelsus (semaglutide) for Type 2 Diabetes

Rybelsus (semaglutide) for Type 2 Diabetes: What You Need to Know

In today’s evolving healthcare landscape, the quest for better solutions for chronic conditions never ceases. Type 2 diabetes, a predominant form of diabetes affecting millions globally, has seen significant strides in treatment modalities. One such breakthrough is Rybelsus (semaglutide). As with any new medication, potential users have queries about its procurement, especially from online avenues and international markets like India. Let’s unravel the answers.

Introducing Rybelsus (semaglutide)

Rybelsus stands out as an oral tablet form of the glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide. While injectable GLP-1 agonists have been available, Rybelsus marks a transformation in administration convenience as an oral drug, making diabetes management less daunting for many.

Accessibility and Prescription Norms

Like many specialized medications, Rybelsus typically requires a prescription, how to buy without prescription read here. This ensures that its intake is tailored to individual needs and is under medical supervision, considering potential side effects and interactions with other drugs.

Those considering Rybelsus should consult their endocrinologist or primary care physician to evaluate its suitability and discuss the dosage.

Venturing Online for Rybelsus

With the digital era in full swing, online pharmacies have become a popular source for many. However, a few considerations are vital:

  • Verification: Always source medications from verified online pharmacies with credible certifications.
  • Prescription Mandate: Reliable platforms often request a prescription before processing an order for regulated drugs.
  • Beware of Counterfeits: The risk of counterfeits is real. Ensure the chosen platform has robust checks in place to guarantee the authenticity of medicines.

Indian Pharmacies and Rybelsus

India, known as the pharmacy of the world, has gained traction for providing quality medications at competitive prices. If considering Indian pharmacies for Rybelsus:

  • Regulatory Standards: Ensure the pharmacy adheres to the Indian regulatory standards, ensuring the drug’s quality and authenticity.
  • Shipping and Customs: Be aware of international shipping charges and potential customs restrictions or fees when ordering from overseas.
  • Prescription Recognition: Some Indian pharmacies might still require a prescription, even if it’s from another country.

Final Thoughts

Rybelsus presents a promising avenue for those managing type 2 diabetes. However, sourcing the medication requires due diligence, whether procured domestically, online, or internationally. Prioritize health and safety by always discussing with healthcare professionals and ensuring authentic sourcing. This not only guarantees the best results from the medication but also secures peace of mind in the treatment journey.

NCDJ and The New York Times Renew Disability Reporting Fellowship

The National Center on Disability and Journalism is partnering for a third year with The New York Times on a fellowship to develop journalists with an expertise in coverage of disability issues.

Early career journalists are encouraged to apply for the one-year fellowship to cover disability issues and people with disabilities as part of the incoming New York Times Fellowship class.

The Disability Journalism Fellowship is designed to address the lack of coverage of disability issues in journalism. It will provide fellows with mentorship, a peer network and training on covering disabilities. The position is funded through the Ford Foundation’s philanthropic support.

Applications will be accepted through March 24.

For more information, see the full release.

NCDJ and The New York Times Renew Disability Reporting Fellowship

The New York Times and the National Center on Disability and Journalism
announced that they are, for the third year in a row, partnering on a fellowship to
develop journalists with an expertise in coverage of disability issues.

This program again will recruit an early career journalist to work at The Times for
one year as a member of the incoming New York Times Fellowship class. The
newsroom is prepared to hire another Disability Journalism Fellow in early 2024.
The Disability Journalism Fellowship is designed to address the lack of coverage
of disability issues in journalism. It will provide fellows with mentorship, a peer
network and training on covering disabilities. The position is funded through the
Ford Foundation’s philanthropic support.

The application for 2023 is now open.
The New York Times Fellowship is a one-year work program aimed at cultivating
and diversifying the next generation of journalists. Since 2019, it has trained
more than 120 participants in reporting, visual, audio and other
disciplines. Amanda Morris, the inaugural Disability Journalism Fellow, is now a
reporter covering the disability community for The Washington Post. Neelam
Bohra, the current Disability Journalism Fellow, will complete her fellowship in
May.

The National Center on Disability and Journalism is a service of the Walter
Cronkite School of Journalism and Mass Communication at Arizona State
University. For over a decade at Cronkite, the center has provided support and
training for journalists and other communications professionals with the goal of
improving media coverage of disability issues and people with disabilities.

The “Weekend Pill” Every Man Should Know About

Gone are the days when Viagra was the sole talk of the town for men’s sexual health. Now, we have a competitor in the market—Cialis, a pill that has earned its nickname, the “weekend pill.” In this article, we delve into the story of Cialis, its advantages, and why it might just be the solution many men have been searching for.

Understanding Cialis and Its Rise to Popularity

1. The Science Behind Cialis

The potency of Cialis springs from its primary ingredient: Tadalafil. This component is a highly selective reverse inhibitor of PDE-5 (type 5 phosphodiesterase). Interestingly, Tadalafil’s selectivity is seven times more potent than Sildenafil, which powers the renowned Viagra. When a man takes Cialis, Tadalafil triggers the release of nitric oxide, leading to the expansion of blood vessels in the pelvic region—thus setting the stage for improved erection quality.

2. The Birth of Cialis

Icos Corporation, upon discovering Tadalafil’s properties, believed it to be a promising solution for erectile dysfunction. Later, the rights to the medication were acquired by the reputed American pharmaceutical giant, Eli Lilly.

Why Erectile Dysfunction Is More Than Just a Physical Concern

Sexual disorders can be emotionally crippling, especially for men. Among issues like reduced libido, arousal disturbances, and orgasmic issues, erectile dysfunction (ED) hits the hardest. It’s not just about physical intimacy; it’s about a man’s self-worth and confidence. In fact, the weight of ED can be so burdensome that it sometimes leads to severe psychological trauma—even pushing some to the brink of despair.

Modern medicine understands the depth of this issue. Potency isn’t just about reproduction; it’s about mental health and self-esteem. When we talk about the causes of ED, they range from vascular diseases and testosterone deficiency to diabetes and physical injuries. With over 150 million global cases and an alarming statistic that more than half of men over forty are at risk, it’s no wonder that drugs like Cialis have become indispensable.

The Economics of Cialis: Quality Treatment at an Affordable Price

While Cialis has made its mark in treating erectile dysfunction, the economic aspect cannot be overlooked. Every man deserves the right to affordable treatment. No individual should find himself in a paradox where he spends most of his earnings on medication, compromising his quality of life.

Therefore, the pressing question for many is: Where can one find quality Cialis without prescription? It’s a crucial consideration because a medicine’s effectiveness isn’t its only virtue—it should be economically viable as well.

In Conclusion

Cialis, with its compelling scientific backing and promising results, has reshaped the discourse on men’s sexual health. For those navigating the challenge of ED, it’s a beacon of hope—not just for physical wellness but also for psychological well-being. However, while seeking treatment, remember that affordability is key. After all, health should enhance life, not hinder it.

Study Shows More Disability Stories Onscreen, but Few Disabled Actors

Let’s start with the good news: Significant depictions of disability on film and television shows have nearly tripled over the past decade compared with the previous 10 years.

Almost all of those titles, however, still don’t feature disabled actors.

The study published Wednesday also showed that television is far behind film when it comes to representation of characters with disabilities.

Read the full story here.